Canada approves generic version of Wegovy for weight loss
FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) –…
Novo Nordisk A/S (NVO) Primary Owner to Open Obesity Drug Incubators Across Europe
Novo Nordisk A/S (NYSE:NVO) is among the Best Pharmaceutical Stocks. On June 19, Novo Nordisk A/S (NYSE:NVO)’s primary owner,…
UPS invests $48 million in cold-chain healthcare logistics
A $48 million buildout of 27 temperature-controlled facilities spanning the Americas, Europe, and Asia is underway at UPS,…
Can Wegovy Pill’s Europe Push Help NVO Offset Mounting Pressures?
Last week, Novo Nordisk NVO secured a key regulatory win with the U.K. approval of the Wegovy pill…
Oral Wegovy Captures One-Third of Prescriptions as Adoption Continues to Accelerate
tablets pills medicine bottle NEW SIZE ©PXHere Novo Nordisk (NYSE:NVO) is seeing strong uptake of its oral Wegovy…
The Latest Ozempic Side Effect? It May Make You Less Violent
Topline GLP-1 medications like Ozempic and Wegovy may reduce the risk of violent criminal behavior among current users,…
3 Ridiculously Cheap Healthcare Stocks to Buy in June
Quick Read NVO sits 44% below its 52-week high with a price-to-free-cash-flow of 5 and a free cash…
Novo Nordisk comeback stirs as Wegovy pill wins UK approval
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s Wegovy (semaglutide) pill, marking another…
Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?
The pharmaceutical industry is highly competitive and driven by innovation. Those two facts couldn’t be on any clearer…
Generic semaglutide market shows signs of excess inventory bulge | Industry News
Pharmarack data indicates elevated stock levels across several recently launched brands amid slower-than-expected liquidation in the trade…
Can Wegovy Pill’s Rapid Uptake Give Novo Nordisk an Edge Over LLY?
Novo Nordisk NVO remains one of the dominant players in the rapidly expanding obesity treatment market. The company markets…
Novo Nordisk shares retreat after ADA conference updates fail to excite investors (NVO)
chart down red arrow NEW SIZE ©Shutterstock Novo Nordisk (NYSE:NVO) shares fell 3% on Monday as investors digested…